ACELYRIN, INC Company Leadership
| SLRN Stock | USD 1.99 0.03 1.53% |
ACELYRIN, INC's insiders are aggressively selling. The analysis of the overall insider sentiment regarding ACELYRIN, INC Common suggests that virtually all insiders are panicking. ACELYRIN, INC employs about 135 people. The company is managed by 15 executives with a total tenure of roughly 315 years, averaging almost 21.0 years of service per executive, having 9.0 employees per reported executive.
ACELYRIN, INC's Insider Buying Vs Selling
0
Selling | Buying |
Latest Trades
| 2024-07-17 | Daniel J Becker | Disposed 1 @ 6.86 | View | ||
| 2024-02-20 | Shao-Lee Lin | Disposed 15701 @ 7.6 | View |
Monitoring ACELYRIN, INC's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
ACELYRIN, |
ACELYRIN, INC Management Team Effectiveness
The company has return on total asset (ROA) of (0.3289) % which means that it has lost $0.3289 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.4195) %, meaning that it created substantial loss on money invested by shareholders. ACELYRIN, INC's management efficiency ratios could be used to measure how well ACELYRIN, INC manages its routine affairs as well as how well it operates its assets and liabilities. As of the 24th of January 2025, Return On Tangible Assets is likely to drop to -0.62. In addition to that, Return On Capital Employed is likely to drop to -0.78. At this time, ACELYRIN, INC's Non Current Assets Total are very stable compared to the past year. As of the 24th of January 2025, Other Assets is likely to grow to about 4.7 M, while Total Assets are likely to drop about 431.9 M.As of the 24th of January 2025, Common Stock Shares Outstanding is likely to drop to about 40.7 M. In addition to that, Net Loss is likely to drop to about (61.2 M)
ACELYRIN, INC Workforce Comparison
ACELYRIN, INC Common is currently regarded as top stock in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 78,926. ACELYRIN, INC adds roughly 135 in number of employees claiming only tiny portion of equities under Health Care industry.
ACELYRIN, INC Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific ACELYRIN, INC insiders, such as employees or executives, is commonly permitted as long as it does not rely on ACELYRIN, INC's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, ACELYRIN, INC insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Murugan Amar over a week ago Insider Trading | ||
Murugan Amar over a month ago Acquisition by Murugan Amar of 525000 shares of ACELYRIN, INC at 4.73 subject to Rule 16b-3 | ||
Labrucherie Gil M over three months ago Disposition of tradable shares by Labrucherie Gil M of ACELYRIN, INC subject to Rule 16b-3 | ||
Labrucherie Gil M over three months ago Acquisition by Labrucherie Gil M of 150000 shares of ACELYRIN, INC at 4.78 subject to Rule 16b-3 | ||
Cozadd Bruce C over three months ago Disposition of 23243 shares by Cozadd Bruce C of ACELYRIN, INC at 18.0 subject to Rule 16b-3 | ||
Becker Daniel J. over six months ago Disposition of tradable shares by Becker Daniel J. of ACELYRIN INC at 6.86 subject to Rule 16b-3 | ||
Lin Shaolee over six months ago Sale by Lin Shaolee of 15701 shares of ACELYRIN INC | ||
Lin Shaolee over a year ago Acquisition or disposition of ACELYRIN INC securities by Lin Shaolee |
ACELYRIN, INC Notable Stakeholders
An ACELYRIN, INC stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as ACELYRIN, INC often face trade-offs trying to please all of them. ACELYRIN, INC's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting ACELYRIN, INC's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Mina JD | CEO Director | Profile | |
| ShaoLee MD | CEO CoFounder | Profile | |
| Patricia Turney | Chief Officer | Profile | |
| Kenneth Lock | Chief Officer | Profile | |
| Gilbert JD | Principal Officer | Profile | |
| Shephard MD | Senior Development | Profile | |
| Kelly Chow | Chief Officer | Profile | |
| Ron Oyston | Chief Officer | Profile | |
| Sanam JD | Chief People | Profile | |
| Tyler Marciniak | Head Communications | Profile | |
| Melanie BSN | Chief Officer | Profile | |
| Suzy CPA | Senior Accounting | Profile | |
| Mina Kim | Chief Officer | Profile | |
| Amar JD | Chief Officer | Profile | |
| MSc MD | Chief Officer | Profile |
About ACELYRIN, INC Management Performance
The success or failure of an entity such as ACELYRIN, INC Common often depends on how effective the management is. ACELYRIN, INC management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of ACELYRIN, management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the ACELYRIN, management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.59) | (0.62) | |
| Return On Capital Employed | (0.74) | (0.78) | |
| Return On Assets | (0.59) | (0.62) | |
| Return On Equity | (0.67) | (0.64) |
ACELYRIN, INC Workforce Analysis
Traditionally, organizations such as ACELYRIN, INC use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare ACELYRIN, INC within its industry.ACELYRIN, INC Manpower Efficiency
Return on ACELYRIN, INC Manpower
| Revenue Per Employee | 0.0 | |
| Revenue Per Executive | 0.0 | |
| Net Loss Per Employee | 2.8M | |
| Net Loss Per Executive | 25.4M | |
| Working Capital Per Employee | 4.8M | |
| Working Capital Per Executive | 43.4M |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in ACELYRIN, INC Common. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ACELYRIN, INC. If investors know ACELYRIN, will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ACELYRIN, INC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of ACELYRIN, INC Common is measured differently than its book value, which is the value of ACELYRIN, that is recorded on the company's balance sheet. Investors also form their own opinion of ACELYRIN, INC's value that differs from its market value or its book value, called intrinsic value, which is ACELYRIN, INC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ACELYRIN, INC's market value can be influenced by many factors that don't directly affect ACELYRIN, INC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ACELYRIN, INC's value and its price as these two are different measures arrived at by different means. Investors typically determine if ACELYRIN, INC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ACELYRIN, INC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.